Efficacy and safety of Tuina therapy for children with combined allergic rhinitis and asthma syndrome in remission: a randomized controlled trial protocol - Summary - MDSpire

Efficacy and safety of Tuina therapy for children with combined allergic rhinitis and asthma syndrome in remission: a randomized controlled trial protocol

  • By

  • Xin Yun Chia

  • Junhao Cai

  • Dan Dai

  • Qing Ji

  • Shijian Liu

  • Wenyi Wang

  • Mengran Si

  • Yan Yang

  • Ping Lu

  • Xiaoqiu Wang

  • Sijie Dang

  • Yi Zhong

  • Shuxia Wang

  • Guimao Wang

  • Bin Xiao

  • June 23, 2026

  • 0 min

Share

Objective:

To assess the clinical efficacy and safety of pediatric Tuina in the treatment of CARAS.

Approach:
    Key Findings:
    • CARAS is a prevalent chronic respiratory disorder among children, significantly impairing quality of life.
    • Current management relies on pharmacotherapy, which may have adverse effects and poor long-term adherence.
    • Pediatric Tuina has shown promise in treating pediatric respiratory conditions but lacks rigorous trials specifically for CARAS.
    Interpretation:

    This study aims to assess the efficacy and safety of pediatric Tuina in improving CARAS symptoms and quality of life in children.

    Limitations:
    • The study is limited to a single center, which may affect generalizability.
    • Assessors will be blinded to group allocation to mitigate bias.
    Conclusion:

    The study aims to provide evidence for a non-pharmacological Traditional Chinese Medicine intervention in the clinical management of CARAS.

    Sources:

Original Source(s)

Related Content